{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:25:34Z","timestamp":1781198734731,"version":"3.54.1"},"reference-count":44,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Secondary malignant tumors of the pancreas are rare, representing 2\u20135% of all pancreatic malignancies. Nevertheless, the pancreas is one of the target organs in cases of metastatic clear cell renal cell carcinoma (CCRCC). Additionally, recurrent metastasis may occur. Surgical resection remains the best and prognostically most favorable therapeutic option in cases of solitary pancreatic metastasis. Aim: To review retrospectively the clinical tumor registry of the University Hospital of Magdeburg, Germany, for this rare entity, performing a clinical systematic single-center observational study (design). Methods: A retrospective cohort analysis of consecutive patients who had undergone pancreatic resection for metastatic CCRC was performed in a single high-volume certified center for pancreatic surgery in Germany from 2010 to 2022. Results: All patients (n = 17) included in this study had a metachronous metastasis from a CCRCC. Surgery was performed at a median time interval of 12 (range, 9\u201316) years after primary resection for CCRCC. All 17 patients were asymptomatic at the time of diagnosis. Three of those patients (17.6%) presented with recurrent metastasis in a different part of the pancreas during follow-up. In a total of 17 patients, including those with recurrent disease, a surgical resection was performed; Pancreatoduodenectomy was performed in 6 patients (35%); left pancreatectomy with splenectomy was performed in 7 patients (41%). The rest of the patients underwent either a spleen-preserving pancreatic tail resection, local resection of the tumor lesion or a total pancreatectomy. The postoperative mortality rate was 6%. Concerning histopathological findings, seven patients (41%) had multifocal metastasis. An R0 resection could be achieved in all cases. The overall survival at one, three and five years was 85%, 85% and 72%, respectively, during a median follow-up of 43 months. Conclusions: CCRC pancreatic metastases can occur many years after the initial treatment of the primary tumor. Surgery for such a malignancy seems feasible and safe; it offers very good short- and long-term outcomes, as indicated. A repeated pancreatic resection can also be safely performed.<\/jats:p>","DOI":"10.3390\/jcm13071921","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T11:34:58Z","timestamp":1711452898000},"page":"1921","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Pancreas as a Target of Metastasis from Renal Cell Carcinoma: Is Surgery Feasible and Safe? A Single-Center Experience in a High-Volume and Certified Pancreatic Surgery Center in Germany"],"prefix":"10.3390","volume":"13","author":[{"given":"Sara","family":"Al-Madhi","sequence":"first","affiliation":[{"name":"Department of General, Abdominal, Vascular and Transplant Surgery, Otto-von-Guericke University with University Hospital, Leipziger Str. 44, 39120 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Acciuffi","sequence":"additional","affiliation":[{"name":"Department of General, Abdominal, Vascular and Transplant Surgery, Otto-von-Guericke University with University Hospital, Leipziger Str. 44, 39120 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Meyer","sequence":"additional","affiliation":[{"name":"Department of General, Abdominal, Vascular and Transplant Surgery, Otto-von-Guericke University with University Hospital, Leipziger Str. 44, 39120 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0303-1342","authenticated-orcid":false,"given":"Maximilian","family":"D\u00f6lling","sequence":"additional","affiliation":[{"name":"Department of General, Abdominal, Vascular and Transplant Surgery, Otto-von-Guericke University with University Hospital, Leipziger Str. 44, 39120 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmus","family":"Beythien","sequence":"additional","affiliation":[{"name":"Department of General, Abdominal, Vascular and Transplant Surgery, Otto-von-Guericke University with University Hospital, Leipziger Str. 44, 39120 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihailo","family":"Andric","sequence":"additional","affiliation":[{"name":"Department of General, Abdominal, Vascular and Transplant Surgery, Otto-von-Guericke University with University Hospital, Leipziger Str. 44, 39120 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6708-6596","authenticated-orcid":false,"given":"Mirhasan","family":"Rahimli","sequence":"additional","affiliation":[{"name":"Department of General, Abdominal, Vascular and Transplant Surgery, Otto-von-Guericke University with University Hospital, Leipziger Str. 44, 39120 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6248-7086","authenticated-orcid":false,"given":"Roland S.","family":"Croner","sequence":"additional","affiliation":[{"name":"Department of General, Abdominal, Vascular and Transplant Surgery, Otto-von-Guericke University with University Hospital, Leipziger Str. 44, 39120 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3972-1174","authenticated-orcid":false,"given":"Aristotelis","family":"Perrakis","sequence":"additional","affiliation":[{"name":"Department of General, Abdominal, Vascular and Transplant Surgery, Otto-von-Guericke University with University Hospital, Leipziger Str. 44, 39120 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,26]]},"reference":[{"key":"ref_1","unstructured":"(2024, January 18). Epidemiologie des Nierenzellkarzinoms in Deutschland. Available online: https:\/\/edoc.rki.de\/handle\/176904\/6129."},{"key":"ref_2","unstructured":"(2024, January 18). Kidney Cancer. Available online: https:\/\/www.krebsdaten.de\/Krebs\/EN\/Content\/Cancer_sites\/Kidney_cancer\/kidney_cancer_node.htm."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1007\/s00104-020-01331-3","article-title":"Surgical treatment of hepato-pancreatic metastases from renal cell carcinoma","volume":"92","author":"Bauschke","year":"2021","journal-title":"Chirurg"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.semradonc.2021.02.002","article-title":"Stereotactic Ablative Radiation (SAbR) for Oligometastatic RCC","volume":"31","author":"All","year":"2021","journal-title":"Sem. Radiat. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1245\/s10434-014-4256-7","article-title":"Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors","volume":"22","author":"Santoni","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.mpa.0000153337.58105.47","article-title":"Renal cancer cell metastasis into the pancreas: A single-center experience and overview of the literature","volume":"30","author":"Wente","year":"2005","journal-title":"Pancreas"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"943604","DOI":"10.3389\/fsurg.2022.943604","article-title":"Role of metastasectomy in the management of renal cell carcinoma","volume":"9","author":"Mikhail","year":"2022","journal-title":"Front. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(08)61039-9","article-title":"Efficacy of everolimus in advanced renal cell carcinoma: A double-blind, randomised, placebo-controlled phase III trial","volume":"372","author":"Motzer","year":"2008","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Joliat, G.R. (2023). Latest Advances and Future Challenges in Pancreatic Surgery. J. Clin. Med., 12.","DOI":"10.3390\/jcm12010371"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/S1470-2045(20)30436-8","article-title":"Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): Extended follow-up from a randomised, open-label, phase 3 trial","volume":"21","author":"Powles","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.suc.2016.07.013","article-title":"Postpancreatectomy Complications and Management","volume":"96","author":"Malleo","year":"2016","journal-title":"Surg. Clin. N. Am."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_13","unstructured":"Doyle, D.J., Hendrix, J.M., Garmon, E.H., and American Society of Anesthesiologists Classification (2023). StatPearls, StatPearls Publishing LLC."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.eururo.2015.01.005","article-title":"EAU guidelines on renal cell carcinoma: 2014 update","volume":"67","author":"Ljungberg","year":"2015","journal-title":"Eur. Urol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.surg.2016.11.014","article-title":"The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After","volume":"161","author":"Bassi","year":"2017","journal-title":"Surgery"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ijsu.2016.10.025","article-title":"Preferred reporting of case series in surgery; the PROCESS guidelines","volume":"36","author":"Agha","year":"2016","journal-title":"Int. J. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.3748\/wjg.v17.i43.4747","article-title":"Pancreatic metastases from renal cell carcinoma: The state of the art","volume":"17","author":"Ballarin","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"ref_19","first-page":"5879374","article-title":"Gastric Metastasis from Renal Cell Carcinoma, Clear Cell Type, Presenting with Gastrointestinal Bleeding","volume":"2017","year":"2017","journal-title":"Case Rep. Gastrointest. Med."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Sellner, F., Thalhammer, S., and Klimpfinger, M. (2021). Tumour Evolution and Seed and Soil Mechanism in Pancreatic Metastases of Renal Cell Carcinoma. Cancers, 13.","DOI":"10.3390\/cancers13061342"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0016-5107(04)01542-1","article-title":"Metastatic renal cell cancer","volume":"60","author":"Shyu","year":"2004","journal-title":"Gastrointest. Endosc."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0022-5347(05)65640-6","article-title":"The changing natural history of renal cell carcinoma","volume":"166","author":"Pantuck","year":"2001","journal-title":"J. Urol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.eururo.2008.04.056","article-title":"Update on the medical treatment of metastatic renal cell carcinoma","volume":"54","author":"Ravaud","year":"2008","journal-title":"Eur. Urol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/0090-4295(91)80336-6","article-title":"Possible metastatic routes via portacaval shunts in renal adenocarcinoma with liver metastasis","volume":"37","author":"Saitoh","year":"1991","journal-title":"Urology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/bjs.4072","article-title":"High recurrence rate after atypical resection for pancreatic metastases from renal cell carcinoma","volume":"90","author":"Bassi","year":"2003","journal-title":"Br. J. Surg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1245\/s10434-019-07258-2","article-title":"Surgical Resection for Metastatic Tumors in the Pancreas: A Single-Center Experience and Systematic Review","volume":"26","author":"Huang","year":"2019","journal-title":"Ann. Surg. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/jso.26614","article-title":"Enhanced recovery after pancreatic surgery: A prospective randomized controlled clinical trial","volume":"124","author":"Ergenc","year":"2021","journal-title":"J. Surg. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/jso.26251","article-title":"Metastatic renal cell carcinoma to the pancreas: Clinical features and treatment outcome","volume":"123","author":"Shin","year":"2021","journal-title":"J. Surg. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1091-255X(01)80060-3","article-title":"Renal cell carcinoma metastatic to the pancreas: Results of surgical management","volume":"5","author":"Sohn","year":"2001","journal-title":"J. Gastrointest. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000431045","article-title":"Pancreatic Metastases from Tumors in the Urogenital Tract","volume":"2","author":"Strobel","year":"2015","journal-title":"Gastrointest. Tumors."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1001\/archsurg.138.12.1310","article-title":"Changes in morbidity after pancreatic resection: Toward the end of completion pancreatectomy","volume":"138","author":"Wagner","year":"2003","journal-title":"Arch. Surg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1245\/s10434-016-5619-z","article-title":"Long-Term Outcomes of 98 Surgically Resected Metastatic Tumors in the Pancreas","volume":"24","author":"Lee","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e6858","DOI":"10.1097\/MD.0000000000006858","article-title":"Pancreatoduodenectomy (PD) and postoperative pancreatic fistula (POPF): A systematic review and analysis of the POPF-related mortality rate in 60,739 patients retrieved from the English literature published between 1990 and 2015","volume":"96","author":"Pedrazzoli","year":"2017","journal-title":"Medicine"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Moletta, L., Friziero, A., Serafini, S., Grillo, V., Sefora Pierobon, E., Capovilla, G., Valmasoni, M., and Sperti, C. (2023). Safety and Efficacy of Surgery for Metastatic Tumor to the Pancreas: A Single-Center Experience. J. Clin. Med., 12.","DOI":"10.3390\/jcm12031171"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1245\/s10434-007-9782-0","article-title":"Pancreatic metastasis from renal cell carcinoma: Which patients benefit from surgical resection?","volume":"15","author":"Zerbi","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1245\/s10434-014-3821-4","article-title":"Long-term survival after pancreatic resection for renal cell carcinoma metastasis","volume":"21","author":"Schwarz","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Milanetto, A.C., Morelli, L., Di Franco, G., David, A., Campra, D., De Paolis, P., and Pasquali, C. (2020). A Plea for Surgery in Pancreatic Metastases from Renal Cell Carcinoma: Indications and Outcome from a Multicenter Surgical Experience. J. Clin. Med., 9.","DOI":"10.3390\/jcm9103278"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/bjs.10662","article-title":"Randomized clinical trial of laparoscopic versus open pancreatoduodenectomy for periampullary tumours","volume":"104","author":"Palanivelu","year":"2017","journal-title":"Br. J. Surg."},{"key":"ref_39","first-page":"Cd011391","article-title":"Laparoscopic versus open distal pancreatectomy for pancreatic cancer","volume":"4","author":"Riviere","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_40","first-page":"337","article-title":"Metastatic tumors to the pancreas: A systematic review and meta-analysis","volume":"71","author":"Sperti","year":"2016","journal-title":"Minerva Chir."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.hpb.2019.10.017","article-title":"Pancreatic resection for metastatic renal cell carcinoma. A systematic review","volume":"22","author":"Ramia","year":"2020","journal-title":"HPB"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1133832","DOI":"10.3389\/fonc.2023.1133832","article-title":"Treatment strategies for clear cell renal cell carcinoma: Past, present and future","volume":"13","author":"Yang","year":"2023","journal-title":"Front. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.euo.2018.08.028","article-title":"Surgical Metastasectomy in Renal Cell Carcinoma: A Systematic Review","volume":"2","author":"Ouzaid","year":"2019","journal-title":"Eur. Urol. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.18632\/oncotarget.27762","article-title":"Identification of international metastatic renal cell carcinoma database consortium (IMDC) intermediate-risk subgroups in patients with metastatic clear-cell renal cell carcinoma","volume":"11","author":"Guida","year":"2020","journal-title":"Oncotarget"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/7\/1921\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:18:57Z","timestamp":1760105937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/7\/1921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,26]]},"references-count":44,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["jcm13071921"],"URL":"https:\/\/doi.org\/10.3390\/jcm13071921","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,26]]}}}